SAN MATEO, Calif., Oct. 27, 2011 (GLOBE NEWSWIRE) -- NeurogesX, Inc. (Nasdaq:NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will hold a conference call on Monday October 31, 2011 at 4:30 p.m. EDT (1:30 p.m. PDT) to report results for its third quarter ended September 30, 2011.
